Moreover, alpha-1 antitrypsin (A1AT) and elevated genes REG4 and SPINK4 are related to cancer-associated thrombosis (CAT) in CRC according to research by Buijs et al. This suggests that these genes might be used as biomarkers to identify CRC patients [20]. This evidence concerns the gene SERPINA1 and colorectal carcinoma.